DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksSchließen
Referenz
Ruff CT, Giugliano RP, Antman EM. et al.
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Am Heart J 2010;
160 (04) 635-641
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.